General Information of Natural Product (ID: NP0868)
  Natural Product Name
Hyperoside
  Synonyms
Hyperoside; 482-36-0; Hyperin; Hyperosid; Quercetin 3-galactoside; Hyperozide; Quercetin-3-O-galactoside; Quercetin-3-galactoside; Hyperasid; Jyperin; Quercetin 3-O-beta-D-galactopyranoside; Quercetin 3-D-galactoside; UNII-8O1CR18L82; QUERCETIN 3-B-D-GALACTOSIDE; Quercetin 3-beta-D-galactopyranoside; MFCD00016933; quercetin 3-O-galactoside; NSC 407304; CHEMBL251254; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; CHEBI:67486; 8O1CR18L82; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-; quercetin galactoside; CCRIS 9339; p Hyperin; quercetin 3-O-beta-D-glucopyranoside; Quercetin 3-.beta.-D-galactopyranoside; Quercetin 3-O-.beta.-D-galactopyranoside; Hyperin,(S); EINECS 207-580-6; Hyperin (8CI); BIDD:PXR0057; MLS000759538; 2-yloxy)-4H-chromen-4-one; jm5b01461, Compound 84; MEGxp0_000392; SCHEMBL1250514; ACon1_000623; Quercetin 3-O-beta-D-galactoside; BDBM429266; HMS2051H17; HY-N0452; quercetin 3-O--D-galactopyranoside; ZINC3973253; BDBM50241367; s5453; AKOS015896780; 6-(hydroxymethyl)tetrahydro-2H-pyran-; CCG-100970; MCULE-5363142212; NC00220; NCGC00168902-03; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; AS-56199; S600; SMR000466394; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CS-0008982; N1838; Quercetin 3-D-galactoside, >=97.0% (HPLC); AB00639910-03; 3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-; 482H360; 3,3',4',5,7-Pentahydroxyflavone 3-D-galactoside; Hyperoside, primary pharmaceutical reference standard; Q-100530; Q5242815; BRD-K84955386-001-01-1; 3-O-b-D-Galactopyranosyloxy-3',4',5,7-tetrahydroxyflavone; Hyperoside, United States Pharmacopeia (USP) Reference Standard; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #; 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-
Click to Show/Hide
  Formula C21H20O12
  Weight 464.4
  Structure Could Not Find 2D Structure
3D Structure Download 2D Structure Download
  InChI InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15+,17+,18-,21+/m1/s1
  InChI Key OVSQVDMCBVZWGM-DTGCRPNFSA-N
  Isomeric SMILES C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O
  Canonical SMILES C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O
  External Links PubChem ID 5281643
CAS ID 482-36-0
NPASS ID NPC281131
HIT ID C0133
CHEMBL ID CHEMBL251254
  NP Activity Charts   Click to show/hide

 The Content Variation of Natural Product Induced by Different Factor(s)
      Species Name: Amaranthus tricolor genotype VA13
  Factor Name: NaCl Treatment [1]
              Species Info Factor Info
               Experiment Detail
On the basis of previous studies, an antioxidant enriched high yield potential genotype (Accession VA13) was selected for this investigation. This genotype was grown in pots of a rain shelter open field of Bangabandhu Sheikh Mujibur Rahman Agricultural University, Bangladesh (AEZ-28, 24° 23′ north latitude, 90° 08′ east longitude, 8.4 m.s.l.). The seeds were sown in plastic pots (15 cm in height and 40 cm length and 30 cm width) in a randomized complete block design (RCBD) with three replications. N: P2O5:K2O were applied @92:48:60 kg/ha as a split dose. First, in pot soil, @46:48:60 kg ha 1 N: P2O5:K2O and second, at 7 days after sowing (DAS) @46:0:0 kg/ha N: P2O5:K2O. The genotype was grouped into three sets and subjected to four salinity stress treatments that are, 100 mM NaCl, 50 mM NaCl, 25 mM NaCl, and control or no saline water (NS). Pots were well irrigated with fresh water every day up to 10 days after sowing (DAS) of seeds for proper establishment and vigorous growth of seedlings. Imposition of salinity stress treatment was started at 11 DAS and continued up to 40 DAS (edible stage). Saline water (100 mM NaCl, 50 mM NaCl and 25 mM NaCl) and fresh water were applied to respective pots once a day. At 40 DAS the leaves of Amaranthus tricolor were harvested. All the parameters were measured in six samples.
Click to Show/Hide
               Factor Function
At Moderate salinity stress (MSS) and Severe salinity stress (SSS) conditions, leaf color parameters and pigments, vitamins, phenolic acids, flavonoids and antioxidant capacity of A. tricolor leaves were very high compared to control condition. Hence, salt-stressed A. tricolor leaves had a good source of natural antioxidants compared to plant grown in normal cultivation practices.
Click to Show/Hide
               Factor Part Location NP Content
 
No saline water (Control)
Leaves Bangabandhu
NP Content: 1.35 ± 0.02 µg/g fresh weight
 
25 mM NaCl (Low salinity stress)
Leaves Bangabandhu
NP Content: 1.33 ± 0.01 µg/g fresh weight
 
50 mM NaCl (Moderate salinity stress)
Leaves Bangabandhu
NP Content: 2.43 ± 0.01 µg/g fresh weight
 
100 mM NaCl (Severe salinity stress)
Leaves Bangabandhu
NP Content: 2.44 ± 0.02 µg/g fresh weight
      Species Name: Chelidonium majus
  Factor Name: Locality Variation; Harvest Time Variation [2]
              Species Info Factor Info
               Experiment Detail
Aerial parts from five populations of Chelidonium majus were collected from the wild at the flowering stage (hereafter referred to as 'wild') for chemical analysis and biological activity testing during May 2019. Ten randomly selected plantlets were also collected from the same five populations in 2019 and planted in an organically certified experimental field of IES (57° 19′ 11.7″ N 25° 19′ 18.8″ E, 115 m altitude). The plot size was 0.8 m2, and the plant spacing was 0.2 × 0.5 m. A year later, aerial parts were collected during the flowering stage from the same populations in the experimental field (hereafter referred to as 'cultivated').
Click to Show/Hide
               Factor Function
The total content of alkaloids in aqueous ethanol extracts prepared from cultivated C. majus specimens was higher than that observed in extracts prepared from wild-grown plant material. Chelidonine, sanguinarine, and chelerythrine were the main contributors to the total increase in alkaloid content. The cultivation of C. majus did not significantly affect the total content of flavonol glycosides. The observed differences in the phytochemical compositions of the C. majus extracts resulted in significant increases in the cytotoxic activities of the preparations.
Click to Show/Hide
               Factor Part Location NP Content
 
Locality: wild + Harvesting time: 2019
Aerial parts Latvia
NP Content: 220.2 ± 269.9 µg/g
 
Locality: experimental field + Harvesting time: 2020
Aerial parts Latvia
NP Content: 195.9 ± 114.0 µg/g
References
1 Augmentation of leaf color parameters, pigments, vitamins, phenolic acids, favonoids and antioxidant activity in selected Amaranthus tricolor under salinity stress
2 The Cultivation of Chelidonium majus L. Increased the Total Alkaloid Content and Cytotoxic Activity Compared with Those of Wild-Grown Plants